A new annual review from Scientific American is aimed at “fostering a worldwide innovation climate with clarity, not clichés.” The report is called Scientific American Worldview: A Global Biotechnology Perspective. Yali Friedman, author of Building Biotechnology, and Jeremy Abbate discuss the report at the Biotechnology Industry Organization’s annual convention, providing a look at areas where innovation thrives and where it does not. They also discuss the impact of the global economic crisis on innovation.Friedman is also managing editor of the Journal of Commercial Biotechnology and lead editorial consultant for Scientific American Worldview. Jeremy Abbate is the director of Global Media Solutions for Scientific American.BIO represents more than 1,200 biotechnology companies, academic institutions and state biotechnology centers in the United States and 30 other nations.To see Friedman and Abbate discussing the scorecard go to www.moreaboutthat.info, click on BIO Innovation and play or dow...
Genre: Entertainment
by: dwjtelevision
Place a quarter on a soda can with some cold water/tea . The coin jumps when u gently touch the bottle with your hand. the warmth from your hand expands the air which makes the coin move
by: clowntown
musicvideo from www.g-ruffs.com international musicgroup based in Sweden.
by: obbylito
In this one-minute video, Dr. Schlitz explores the possibility that we are now going through the next scientific revolution, one every bit as profound as those created by Copernicus, Darwin, and Einstein.
Genre: News Videos
by: shiftinaction
A drunk guy at a roller derby after party sticking a feather from my uniform in his eye. Why? I have no idea at all, but it made me laugh so hard I shook the camera.
Genre: Funny Videos
by: TheDevilsNextReject
Now next thing on the list is to sit him on the driver seat and turn the engine on
by: Europeanboy
Is it possible to have a heart attack by getting hit in the nuts
by: Indian_Larry
For more info visit www.newsinfusion.comMADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failure Progression Natick, MA and Barcelona (September 1, 2009) — Boston Scientific Corporation (NYSE: BSX) today announced final results from the landmark MADIT-CRT trial, which were published by the New England Journal of Medicine and presented during a Hot Line session at the annual European Society of Cardiology (ESC) Congress in Barcelona. Arthur Moss, M.D., Professor of Medicine at the University of Rochester Medical Center and Principal Investigator of the trial, presented the MADIT-CRT data. The primary endpoint showed that Boston Scientifics cardiac resynchronization therapy defibrillators (CRT-Ds) were associated with a 34 percent relative reduction in the risk of all-cause mortality or first heart failure event in asymptomatic and mild (NYHA Class I and II1) heart failure patients, when compared to standard implantable cardioverter ...
by: newsinfusion
ct imaging
by: rafath
Hot and hilarious comedy actress Cherie Thibodeaux goes ghostbusting in a cemetery in the middle of the night.
by: QualityShows
